Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-09-07 00:00:00 ET · period of report 2022-09-02 · accession 0001209191-22-049025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-07 | 2022-09-02 | PCVX | Fairman Jeff | VP, Research | F - Tax | $26.38 | -519 | 17.1K | -3% | -$13.7K | |
| MI | 2022-09-07 | 2022-09-06 | PCVX | Fairman Jeff | VP, Research | S - Sale | $26.58 | -5,000 | 301.2K | -2% | -$132.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-02 | F | D | 519 | $26.38 | 17,143 | D By Fairman Family Trust | — | — | |
| 2 | Common | Common Stock | 2022-09-06 | S | D | 4,664 | $26.54 | 301,563 | I By Fairman Family Trust | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $26.04 to $27.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-09-06 | S | D | 336 | $27.14 | 301,227 | I | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $27.09 to $27.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |